Yemarshet K Gebreyohannes - Laboratory of Experimental Oncology, KU Leuven

基本信息

Career Trajectory

Bio

Yemarshet K Gebreyohannes currently works at the Department of Pharmacology, University of Minnesota. Yemarshet does research in Oncology, specifically studying breast cancer dormancy and recurrence.

Research Interests

Papers共 50 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure S2 from in Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models

Jasmien Cornillie,Agnieszka Wozniak,Peter Pokreisz,Andrea Casazza,Lise Vreys,Jasmien Wellens,Ulla Vanleeuw,Yemarshet K. Gebreyohannes,Maria Debiec-Rychter,Raf Sciot,Daphne Hompes,Patrick Schöffski

openalex（2023）

Cited0Views0Bibtex

Figure S3 from in Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models

Jasmien Cornillie,Agnieszka Wozniak,Peter Pokreisz,Andrea Casazza,Lise Vreys,Jasmien Wellens,Ulla Vanleeuw,Yemarshet K. Gebreyohannes,Maria Debiec-Rychter,Raf Sciot,Daphne Hompes,Patrick Schöffski

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S1 from Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

Jasmien Cornillie,Agnieszka Woźniak, Haifu Li,Yannick Wang,Bram Boeckx,Yemarshet K. Gebreyohannes,Jasmien Wellens,Ulla Vanleeuw,Daphne Hompes,Marguerite Stas,Friedl Sinnaeve,Hazem Wafa,Diether Lambrechts,Maria Dȩbiec‐Rychter,Raf Sciot,Patrick Schöffski

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S2 from Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors

Yemarshet K. Gebreyohannes,Agnieszka Woźniak, Madalina-Elena Zhai,Jasmien Wellens,Jasmien Cornillie,Ulla Vanleeuw,Erica Evans,Alexandra K. Gardino,Christoph Lengauer,Maria Dȩbiec‐Rychter,Raf Sciot,Patrick Schöffski

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S4 from Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors

Yemarshet K. Gebreyohannes,Agnieszka Wozniak, Madalina-Elena Zhai,Jasmien Wellens,Jasmien Cornillie,Ulla Vanleeuw,Erica Evans,Alexandra K. Gardino,Christoph Lengauer,Maria Debiec-Rychter,Raf Sciot,Patrick Schöffski

crossref（2023）

Cited0Views0Bibtex

In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models

Jasmien Cornillie,Agnieszka Wozniak,Peter Pokreisz,Andrea Casazza,Lise Vreys,Jasmien Wellens,Ulla Vanleeuw,Yemarshet K. Gebreyohannes,Maria Debiec-Rychter,Raf Sciot,Daphne Hompes,Patrick Schoffski

openalex（2023）

Cited0Views0WOSBibtex

Figure S1 from in Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models

Jasmien Cornillie,Agnieszka Wozniak,Peter Pokreisz,Andrea Casazza,Lise Vreys,Jasmien Wellens,Ulla Vanleeuw,Yemarshet K. Gebreyohannes,Maria Debiec-Rychter,Raf Sciot,Daphne Hompes,Patrick Schöffski

crossref（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn